HomeLearnNews

News

October 12, 2017

Avelumab Survey

The purpose of this survey is to provide the Canadian Cancer Survivor Network (CCSN) with insights and perspectives about the use of Avelumab for the treatment of patients with Merkel cell...
Read More
October 2, 2017

Have you experienced a blood clot during cancer treatment?

If you or a loved one has experienced a blood clot after you were diagnosed with cancer or during chemotherapy, you live in Ontario and would like to help CCSN...
Read More
October 2, 2017

Cancer Patients Celebrate New Program for Take-Home Cancer Medications in Nova Scotia

Halifax, Nova Scotia, September 27, 2017 – The CanCertainty Coalition, the united voice of 35 Canadian cancer organizations, applauds the McNeil Government's decision to address the funding gap for take-home...
Read More
September 26, 2017

Watch our webinar titled “How Changes to the Patented Medicine Prices Review Board Could Affect Patients’ Access to Drugs”

This webinar introduces you to the Patented Medicine Prices Review Board (PMPRB), how they regulate drug pricing in Canada and the proposed changes that will affect cancer patients. This webinar...
Read More
September 22, 2017

New First Line Treatment Now Available for Canadians with Metastatic Non-Small Cell Lung Cancer

KIRKLAND, QC, Sept. 20, 2017 /CNW Telbec/ - Merck (NYSE: MRK), known as MSD outside Canada and the United States, announced today that KEYTRUDA® (pembrolizumab) as monotherapy is now indicated for the treatment of metastatic non-small cell...
Read More
September 21, 2017

First-in-class BRCA-positive Ovarian Cancer Medicine Lynparza® (olaparib) Receives Positive pan-Canadian Oncology Drug Review (pCODR) Recommendation for Provincial Reimbursement

This marks an important first step towards providing Canadian women with access to this treatment MISSISSAUGA, ON, Sept. 21, 2017 /CNW/ - AstraZeneca Canada is pleased to announce that the pan-Canadian Oncology Drug...
Read More
September 14, 2017

Cancer-Associated Thrombosis: A Critical Gap in Cancer Care

"Cancer-associated thrombosis (CAT) is one of the most common yet preventable causes of death among cancer patients. With over 20,000 Canadians being diagnosed with cancer each year, knowing about causes,...
Read More
September 13, 2017

Registration Now Open for the Second Annual Drug Pricing Policy Summit

On November 15-16, 2017 from 8:30 a.m. - 5:00 p.m., you are invited to join the Save Your Skin Foundation, the Canadian Cancer Survivor Network and the Schizophrenia Society of...
Read More
September 11, 2017

Saskatchewan latest province to help protect boys from cancer with HPV vaccine

Grade 6 boys in Saskatchewan will now receive a vaccine to prevent some types of cancer. Starting this year 7,500 boys will be eligible to receive the human papillomavirus, or...
Read More
September 8, 2017

pCODR gives initial positive recommendation for Ovarian Cancer Drug

pCODR recently announced their initial positive recommendation for Olaparib (Lynparza), a targeted therapy for ovarian cancer. As part of their recommendation, pCODR stated that "Reimbursement should be for olaparib monotherapy...
Read More
1 … 35 36 37 38 39 … 67